IQVIA Holdings Inc. IQV reported solid fourth-quarter 2019 results, wherein the company’s earnings and revenues surpassed the Zacks Consensus Estimate.
Adjusted earnings per share of $1.74 beat the consensus mark by 1.2% and increased 16% on a year-over-year basis. The reported figure exceeded the midpoint ($1.7) of the guided range of $1.65-$1.75.
Total revenues of $2.9 billion outpaced the consensus estimate by 1.9% and increased 7.7% year over year on a reported basis and 8.5% on a constant-currency basis. The reported figure came above the guided range of $2.807-$2.857 billion.
Shares of IQVIA have gained 22.8% over the past year, against 1.7% decline of the industry it belongs to.
Let’s check out the numbers in detail:
Revenues from Technology & Analytics Solutions (TAS) totaled $1.21 billion, up 7.7% on a reported basis and 9% on a constant-currency basis. The segment accounted for 42% of total revenues.
Research & Development Solutions (R&DS) revenues of $1.47 billion increased 7.5% on a reported basis and 8.1% on a constant-currency basis. The segment contributed 51% to total revenues.
Revenues from Contract Sales & Medical Solutions (CSMS) totaled $210 million, up 8.8% on a reported and 8.3% on a constant-currency basis. The segment accounted for 7% of total revenues.
Adjusted EBITDA was $642 million, up 10.1% year over year. Adjusted EBITDA margin increased to 22.2% from 21.7% in the year-ago quarter.
Operating income was $166 million, down 19.8% from the year-ago quarter. Operating income margin decreased to 5.7% from 7.7% in the year-ago quarter.
Balance Sheet and Cash Flow
IQVIA exited the quarter with cash and cash equivalents balance of $837 million compared with $863 million at the end of the prior quarter. Long-term debt at the end of the quarter was $11.5 billion compared with $11.4 billion at the end of the previous quarter.
The company generated $583 million of cash from operating activities in the reported quarter and CapEx was $137 million.
The company projects adjusted earnings between $7.15 and $7.35 per share. The current Zacks Consensus Estimate of $7.26 lies within the guided range.
Revenues are now expected between $11.8 billion and $12 billion. The current Zacks Consensus Estimate stands at $11.83 billion.
Adjusted EBITDA is now anticipated in the range of $2,565 - $2,620 million.
Zacks Rank & Stocks to Consider
IQV currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank stocks here.
Investors interested in the broader Zacks Business Services sector are awaiting fourth-quarter 2019 earnings of key players like Delphi , Waste Management WM and Republic Services RSG, each scheduled to release results on Feb 13.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
See their latest picks free >>